Acquired cellular immunity to Mycobacterium tuberculosis infection in the mouse consists of a complex series of interactions between various populations of T lymphocytes and mononuclear phagocytes (10, 14, 15, 16) . These populations of T cells can be distinguished in terms of their functions (protective [16] , delayed-type hypersensitivity [DTH] [17] , and memory [18] ) and in terms of various characteristics such as longevity, kinetics of emergence and loss, and the expression of cell surface markers (16) .
It has been a long-held contention both in this laboratory and in others (1, 4, 11, 12, 17, 18) that specific resistance to tuberculosis infection is only efficiently generated against the living organism, thus suggesting that antigens that generate this resistance are elaborated by the viable, metabolizing mycobacterium, but not by the dead organism. This hypothesis has been recently challenged, however, by a series of publications from various laboratories in which there has been a widespread use of various dead mycobacterial preparations to immunize mice for lymphoid tissues from which to propagate reactive cloned T-cell lines (2, 9, 22) .
In view of this trend, various dead mycobacterial vaccine preparations were examined in the present study for their capacity to generate T cells capable of mediating specific acquired resistance in vivo. The results presented provide the first evidence, however, that none of the preparations, with the exception of the live organism, resulted in the generation of protective T cells capable of passively transferring specific immunity.
These experiments were performed with specific-pathogen-free B6D2 (C57BL/6 x DBA/2)F1 hybrid female mice purchased from the Trudeau Institute, Saranac Lake, N.Y. Bacterial strains M. tuberculosis Erdman, Hand, H37Rv, and H37Ra were grown in Proskauer-Beck medium as previously described (16) . For resistance assays, inoculated mice were challenged intravenously with 105 live M. tuberculosis Erdman bacilli; resistance to this challenge was expressed as the log1o difference between numbers of bacteria harvested from the spleens of control mice (n = 4, in all cases) and numbers of bacteria harvested from vaccinated mice. In mice inoculated intravenously with preparations of the Erdman strain, the streptomycin-resistant Hand strain was substituted as the challenge infection (this strain is of equal virulence to the Erdman strain and was distinguished by plating on nutrient agar containing 10 ,ug of streptomycin per ml). Harvests were performed 10 days after challenge; bacteria numbers were determined by plating individual whole-organ homogenates on nutrient agar (16) . Subcutaneous injections were given in both inguinal regions; mice received lyophilized preparations of either dead H37Ra (9) or dead H37Rv (2) emulsified into incomplete Freund adjuvant.
Nonspecific resistance was determined by challenging mice with 105 viable Listeria monocytogenes cells and assessing the growth of this infection in the spleen 48 h later, as previously described (20) . Delayed-type cutaneous responses to tuberculin (purified protein derivative) were measured by injecting mice in a hind footpad with 5 ,ug of this material (Connaught Laboratories, Toronto, Ontario, Canada) and measuring footpad swelling after 3 and 24 h. The generation of protective T cells was measured as their capacity to adoptively protect T-cell-deficient sublethally irradiated (500 rads of ionizing whole-body gamma irradiation) recipients as previously described (21) . Following intravenous inoculations, splenic T cells were transferred; whereas following subcutaneous inoculation, draining lymph node, peritoneal exudate, and splenic T cells were pooled and transferred together. In both cases, cells were enriched for T cells by removal of adherent cells, followed by treatment of nonadherent cells with Jlld.2 monoclonal antibody plus rabbit complement (this monoclonal antibody is lytic for B cells, granulocytes, erythrocytes, and immature T cells [19] ). Recipients received one donor equivalent of T cells given intravenously; controls received similar cells from normal mice.
The results of these various cellular immunity assays are shown in Fig. 1 (Fig. 1) .
Thus, the results of these experiments clearly show that while nonspecific resistance and DTH can be induced by nonliving mycobacterial preparations, only inoculation with the living organism can result in the generation of detectable numbers of protective T cells to this infection. The question arises, therefore, as to the functional relevance of cloned T-cell lines that can be readily generated against dead mycobacterial preparations. It is interesting to note, in this regard, that the lymphokine secretion profile of such lines is similar to that of a number of helper T-cell lines recently characterized by Mosmann and his colleagues (13) 
NOTES
The more recent finding that DTH effector T cells also appear to fall within the helper T-cell population (3), coupled with the observation above that the subcutaneous inoculation of mice with dead mycobacterial preparations in adjuvant can generate DTH in the absence of protective T-cell generation, serve to further distance this population from cells that mediate specific resistance (17) . Moreover, these data also indicate that the antigens that generate DTH effector T cells are contained within dead mycobacterial preparations and are particularly well presented if the preparation is inoculated in a water-in-oil emulsion.
One candidate for these antigens may be the 65-kilodalton somatic heat shock protein that appears to be immunodominant in terms of recognition by cloned T-cell lines (2) , is immunogenic for DTH effector T cells (5), and is a predominant target of monoclonal antibodies raised against mycobacterial sonicates (8) . In view of this body of data, this protein is considered by some as a possible prime candidate for the key antigen encoded into a subunit recombinant vaccine.
The identification of this protein as a material relevant for inclusion in a vaccine may prove to be premature, however, in view of data presented in the present study. The 65-kilodalton protein is the major band in electropherograms of heat-killed M. tuberculosis, and yet even very high numbers of these dead organisms completely failed to generate specific resistance in the experiments described above. Thus, these data suggest that such somatic for constitutive proteins of mycobacteria may serve as targets for DTH effector T cells, but may not be highly immunogenic for protective T cells unless presented in a nonphysiological manner, such as an oil vehicle (17) .
As to the nature of the antigens that do result in protective T-cell generation, the emergence of these cells may be intimately controlled by events occurring early after ingestion of the mycobacteria by phagocytic macrophages. In this regard, a primary mechanism by which living mycobacteria are able to initially successfully proliferate within macrophages is believed to reside in their ability to initially prevent phagosome-lysosome fusion by the host cell, thus avoiding contact with destructive hydrolytic enzymes (6, 7) . In such a scenario, the macrophage would be unable to degrade or process mycobacterial antigens in the conventional sense and so would have to rely on utilization of proteins secreted or exported by the living proliferating organism, such as those that can be found in the filtrates of bacteria cultivated in vitro (1). In addition, peak protective T-cell generation occurs during maximal proliferation of the M. tuberculosis infection (16) .
On the other hand, inhibition of phagolysosomal fusion does not appear to occur in mice inoculated with the dead organism, and thus the major somatic structural proteins on the mycobacterial cell wall exterior would be exposed to the array of lysosomal enzymes. Thus, under the present hypothesis, the primary exterior somatic proteins would result in the generation of helper, rather than protective, T cells. However, the precise rules that govern whether a particular class of protein antigen will give rise to either protective T-cell or helper T-cell populations currently remains completely unknown.
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